Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease

被引:40
|
作者
Escande, Mariela V. [1 ,2 ]
Taravini, Irene R. E. [3 ,4 ,5 ]
Zold, Camila L. [1 ,2 ]
Belforte, Juan E. [1 ,2 ]
Gustavo Murer, M. [1 ,2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, IFIBIO Bernardo Houssay, Syst Neurosci Grp, RA-1121 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, RA-1121 Buenos Aires, DF, Argentina
[3] Consejo Nacl Invest Cient & Tecn, ININFA, Expt Parkinsonism Grp, RA-1121 Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, RA-1121 Buenos Aires, DF, Argentina
[5] Univ Entre Rios, Expt Neurobiol Lab, RA-2820 Concepcion Del Uruguay, Entre Rios, Argentina
来源
JOURNAL OF NEUROSCIENCE | 2016年 / 36卷 / 21期
关键词
6-OHDA; functional connectivity; in vivo electrophysiology; medium spiny neurons; striatum; STRIATAL PROJECTION NEURONS; MEDIUM SPINY NEURONS; EXTERNAL GLOBUS-PALLIDUS; BAC TRANSGENIC MICE; BASAL GANGLIA; IN-VIVO; STRIATOPALLIDAL NEURONS; L-DOPA; FEEDFORWARD INHIBITION; NIGROSTRIATAL DAMAGE;
D O I
10.1523/JNEUROSCI.0492-15.2016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The characteristic slowness of movement in Parkinson's disease relates to an imbalance in the activity of striatal medium spiny neurons (MSNs) of the direct (dMSNs) and indirect (iMSNs) pathways. However, it is still unclear whether this imbalance emerges during the asymptomatic phase of the disease or if it correlates with symptom severity. Here, we have used in vivo juxtacellular recordings and transgenic mice showing MSN-type-specific expression of fluorescent proteins to examine striatal imbalance after lesioning dopaminergic neurons of the substantia nigra. Multivariate clustering analysis of behavioral data discriminated 2 groups of dopamine-lesioned mice: asymptomatic (42 +/- 7% dopaminergic neuron loss) and symptomatic (85 +/- 5% cell loss). Contrary to the view that both pathways have similar gain in control conditions, dMSNs respond more intensely than iMSNs to cortical inputs in control animals. Importantly, asymptomatic mice show significant functional disconnection of dMSNs from motor cortex without changes in iMSN connectivity. Moreover, not only the gain but also the timing of the pathways is altered in symptomatic parkinsonism, where iMSNs fire significantly more and earlier than dMSNs. Therefore, cortical drive to dMSNs decreases after partial nigrostriatal lesions producing no behavioral impairment, but additional alterations in the gain and timing of iMSNs characterize symptomatic rodent parkinsonism.
引用
收藏
页码:5686 / 5698
页数:13
相关论文
共 50 条
  • [21] Neuroinflammation in the MPTP mouse model and in Parkinson's disease
    Przedborski, S
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 24 - 24
  • [22] Protocol for the MPTP mouse model of Parkinson's disease
    Vernice Jackson-Lewis
    Serge Przedborski
    Nature Protocols, 2007, 2 : 141 - 151
  • [23] Proteasomal gene ablation in a novel mouse model of Parkinson's disease activates a mechanism to maintain proteasome homeostasis
    Paine, S. M. L.
    Mee, M.
    Bedford, L.
    Lowe, J. S.
    Mayer, R. J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 26 - 26
  • [24] Iron homeostasis and Parkinson's disease
    Faucheux, BA
    Hirsch, EC
    ANNALES DE BIOLOGIE CLINIQUE, 1998, 56 : 23 - 30
  • [25] Work Loss and Direct and Indirect Costs Associated with Parkinson?s Disease
    Jerry, Michelle
    Arcona, Steve
    McMorrow, Donna
    Schwartz, Hana
    Princic, Nicole
    Sasane, Rahul
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 309 - 319
  • [26] Caspase-11 is a KEY mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
    Furuya, T
    Mochizuki, H
    Yoshimi, K
    Hayakawa, H
    Miura, M
    Mizuno, Y
    MOVEMENT DISORDERS, 2004, 19 : S33 - S33
  • [27] Bone loss in MPTP mouse model of Parkinson's disease is triggered by decreased osteoblastogenesis and increased osteoclastogenesis
    Ali, Shaheen Jafri
    Ellur, Govindraj
    Khan, Md Touseef
    Sharan, Kunal
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 363 : 154 - 163
  • [28] Silibinin Prevents Dopaminergic Neuronal Loss in a Mouse Model of Parkinson's Disease Via Mitochondrial Stabilization
    Lee, Yujeong
    Park, Hee Ra
    Chun, Hye Jeong
    Lee, Jaewon
    JOURNAL OF NEUROSCIENCE RESEARCH, 2015, 93 (05) : 755 - 765
  • [29] An Angiogenic Inhibitor Reduces Dopamine Neuron Loss and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
    Patel, A.
    Desai, B.
    Carvey, P. M.
    Hendey, B.
    CELL TRANSPLANTATION, 2010, 19 (03) : 356 - 356
  • [30] Transcriptome modification of anodal transcranial direct current stimulation in transgenic Parkinson's disease mouse model
    Jang, W.
    Kim, H. -T.
    MOVEMENT DISORDERS, 2019, 34 : S891 - S891